Literature DB >> 2642893

Levels of myc protein, as analyzed by flow cytometry, correlate with cell growth potential in malignant B-cell lymphomas.

H Holte1, T Stokke, E Smeland, R Watt, H K Blomhoff, O Kaalhus, R Ohlsson.   

Abstract

We have analyzed c-myc protein expression during the cell cycle in malignant B-cell lymphomas by dual flow cytometric detection of a fluoresceinated polyclonal anti-myc antibody and propidium iodide which binds stochiometrically to DNA. The data obtained were correlated to other parameters of cell activation such as histopathological grading, expression of the activation antigen 4F2, light scatter (proportional to cellular volume), DNA synthesis and percentage of S-phase cells. The c-myc protein level was strongly correlated to parameters of DNA synthesis/content. In addition, the oncoprotein level was largely unvarying from the late G1 phase through the rest of the cell cycle in both malignant cells and normal purified B cells stimulated to proliferate in vitro.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2642893     DOI: 10.1002/ijc.2910430130

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

1.  Asymmetric distribution of oncogene products at mitosis.

Authors:  B Czerniak; F Herz; R P Wersto; L G Koss
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

2.  Interspecies comparison of c-myc gene in human and rat glioma cell lines.

Authors:  H Shindo; E Tani; N Kochi; K Kaba; T Matsumoto; K Miyaji; Y Yamamoto; J Furuyama
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

3.  Stabilization of c-myc protein in human glioma cells.

Authors:  H Shindo; E Tani; T Matsumuto; T Hashimoto; J Furuyama
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

4.  Induction of an autoimmune response against syngeneic lymphoma cells by immunogenic 64-kDa protein isolated from normal blast cells of BALB/c mice.

Authors:  R Stock; D Naor
Journal:  Cancer Immunol Immunother       Date:  1995-01       Impact factor: 6.968

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.